Please login to the form below

Not currently logged in
Email:
Password:

key accounts

This page shows the latest key accounts news and features for those working in and with pharma, biotech and healthcare.

Key Accounts

Key Accounts

These may however not be conventional customers, so measuring key accounts in terms of standard metrics like customer coverage or frequency may be counterproductive. ... To date, however, most companies still struggle with what constitutes a key account

Latest news

  • A difficult journey A difficult journey

    Healthcare accounts can be segmented based on needs. Having defined 'key accounts', we must then delve deeper to see what kind of key account we are dealing with - this very much ... An alternative approach focusing on KPIs has led to quick-wins due to

  • McCann wins Reckitt Benckiser account McCann wins Reckitt Benckiser account

    Havas Worldwide, which previously handled the Air Wick, Clearasil and Finish accounts, 'continues to be a key agency partner and retains the rest of the extensive brand portfolio', Reckitt Benckiser said ... This includes plans to spin out its pharma

  • Kane & Finkel closes Kane & Finkel closes

    Independent agency unable to survive loss of several key accounts. The independent healthcare marketing agency Kane &Finkel has shut up shop due to the loss of several key accounts. ... The first quarter of 2013 saw the San Francisco-based agency lose

  • Access The Netherlands

    Headcount was reduced by 50 per cent; sales representatives were been replaced by key accounts managers (KAMs) and companies are recognising the need for proper reimbursement and the impact of ... Key challenge. This is the key challenge facing

  • European Commission outlines R&D future

    The comments were welcomed by EuropaBio. It believes that the five key elements at the core of the CSF should be:. ... China is also catching up with Europe fast, where it now accounts for 1.4 per cent.

More from news
Approximately 1 fully matching, plus 14 partially matching documents found.

Latest Intelligence

  • KAM 2.0 KAM 2.0

    What is a ‘Lighthouse Accounts Boost Programme’? It focuses on creating quick wins with a few selected large key accounts through value- oriented partnerships. ... These first movers will learn more and more about their key accounts’ needs, making

  • Bridging pharma’s digital gap Bridging pharma’s digital gap

    But we predict that reps will play a part in the overall system, both to manage key accounts and in executional roles. ... Reducing cost is a key driver. The old way of doing things is very expensive.

  • Key accounts - origins, responsibilities and differences Key accounts - origins, responsibilities and differences

    Delineating key accounts solely on the basis of absolute sales may therefore be misleading. ... Reports produced should mirror, support and drive this process. Key accounts are different and should be treated as such.

  • An effective commercial model for cancer care An effective commercial model for cancer care

    Emphasising patient-provider communication in cancer care reduces healthcare costs incurred by payers and other key accounts in the healthcare environment.

  • Benchmarking product launches via online networks Benchmarking product launches via online networks

    He then spent over 10 years running high profile accounts within a number of leading digital advertising agencies, delivering several award-winning communication campaigns. ... As Business Director, Michael leads a range of key client accounts and also

More from intelligence
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest appointments

  • Healthcare comms appointments Healthcare comms appointments

    She will also oversee a number of key accounts. Gareth Thomas, Managing Director of Wilmington Healthcare, said: “ Having worked in sales, marketing and business management roles within the healthcare industry for

  • Kelly Warth joins the P/S/L Group network Kelly Warth joins the P/S/L Group network

    GfK. In her most recent role as UK head of health and global business development at GfK, Warth developed and managed the overall business, as well as built key relationships with ... global accounts.

  • Simon Doyle joins STEM Simon Doyle joins STEM

    Doyle - who joins the group from Intercept Pharmaceuticals where he was executive director of commercial operations and marketing - will be at the forefront of a number of key accounts to help

  • Gareth Thurston joins Wilmington Healthcare as an account director Gareth Thurston joins Wilmington Healthcare as an account director

    Wilmington Healthcare has appointed Gareth Thurston as an account director to oversee a number of key accounts across its portfolio.

  • Havas Lynx boosts medical team Havas Lynx boosts medical team

    Also joining Havas Lynx's medical team, Dr Ben Harman-Jones and Dr Yasmin Ghani will specialise in providing medical expertise across the agency's key accounts.

More from appointments
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics